CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma

Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumor in adults. Current treatment options typically consist of surgery followed by chemotherapy or more frequently radiotherapy, however, median patient survival remains at just over 1 year. Therefore, the need...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggs, Luke, Cattaneo, Giulia, Dal, Ali Emre, Moghaddam, Ali Sanjari, Ferrone, Soldano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185049/
https://www.ncbi.nlm.nih.gov/pubmed/34113233
http://dx.doi.org/10.3389/fnins.2021.662064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185049/
https://www.ncbi.nlm.nih.gov/pubmed/34113233
http://dx.doi.org/10.3389/fnins.2021.662064

Ejemplares similares